Mangoceuticals, Inc. Common Stock

MGRXNASDAQUSD
0.52 USD
0.02 (3.00%)🟢PRE MARKET (AS OF 05:37 AM EDT)
🟢Market: OPEN

Mangoceuticals, Inc. Common Stock (MGRX) is currently trading at $0.52. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, MGRX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 12, 2026.

Open?$0.54
High?$0.54
Low?$0.51
Prev. Close?$0.53
Volume?14.0K
Avg. Volume?25.0M
VWAP?$0.53
Rel. Volume?0.00x
Bid / Ask
Bid?$0.46 × 100
Ask?$0.62 × 100
Spread?$0.16
Midpoint?$0.54
Valuation & Ratios
Market Cap?9.1M
Shares Out?17.2M
Float?15.2M
Float %?89.4%
P/E Ratio?N/A
P/B Ratio?0.68
EPS?-$1.17
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Employees
N/A
Market Cap
9.2M
Industry
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Listed
2023-03-21
Address
15110 DALLAS PKWY, SUITE 600
DALLAS, TX 75248
Phone: (833) 626-4679
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
50
Short Sent.?
43
Piotroski F-Score?3/9Weak
Altman Z-Score?-7.90Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.40%High
Short Interest?1.9M
Days to Cover?1.0
Free Float15.2M
Avg Daily Volume49.4M
Settlement Date2026-07-31
Financial Health
Current Ratio?0.29Weak
Quick Ratio?0.29Weak
Cash Ratio?0.24Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.68CHEAP
P/S?
Peers
100
S&P
3
21.95HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.6CHEAP
EV/Sales?
Peers
100
S&P
3
21.53HIGH
Returns & Efficiency
ROE?
S&P
3
-149.1%WEAK
ROA?
S&P
3
-139.0%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$8.9M
Fundamentals ratios updated end of day